Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors

American Journal of Ophthalmology

Volumn 156, Issue 1, 2013, Pages

  Ho, Vincent Y ^a   Yeh, Steven ^a   Olsen, Timothy W ^a   Bergstrom, Chris S ^a   Yan, Jiong ^a   Cribbs, Blaine E ^a   Hubbard III, G Baker ^a  

^a EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; RANIBIZUMAB;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; ENDOPHTHALMITIS; FEMALE; HEART INFARCTION; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84879209123     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.02.009     Document Type: Article

References (21)

1. D.S. Friedman, B.J. O'Colmain, and B. Munoz The Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 4 2004 564 572
2. N.M. Bressler Age-related macular degeneration is the leading cause of blindness JAMA 291 15 2004 1900 1901
3. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
4. P.G. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
5. R.L. Avery, D.J. Pieramici, M.D. Rabena, A.A. Casterllarin, M.A. Nasir, and M.J. Giust Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 3 2006 363 372
6. P. Abraham, H. Yue, and L. Wilson Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2 Am J Ophthalmol 150 3 2010 315 324
7. D.F. Martin, M.G. Maguire, S.L. Fine CATT Research Group Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
8. U. Chakravarthy, S.P. Harding, C.A. Rogers IVAN Study Investigators Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 7 2012 1399 1411
9. J.S. Heier, D.M. Brown, and V. Chong Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration Ophthalmology 119 12 2012 2537 2548
10. D.J. Browning, P.K. Kaiser, P.J. Rosenfeld, and M.W. Stewart Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol 154 2 2012 222 226
11. J. Holash, S. Davis, and N. Papadopoulos VEGF-Trap: a VEGF blocker with potent antitumor effects Proc Natl Acad Sci U S A 99 17 2002 11393 11398
12. N. Papadopoulos, J. Martin, and Q. Run Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Angiogenesis 15 2 2012 171 185
13. M.W. Stewart, and P.J. Rosenfeld Predicted biological activity of intravitreal VEGF Trap Br J Ophthalmol 92 5 2008 667 668
14. J.A. Dixon, S.C. Oliver, J.L. Olson, and N. Mandava VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration Expert Opin Investig Drugs 18 10 2009 1573 1580
15. J.T. Holladay Proper method for calculating average visual acuity J Refract Surgery 13 4 1997 388 391
16. F. Forooghian, C. Cukras, C.B. Meyerle, E.Y. Chew, and W.T. Wong Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration Retina 29 6 2009 723 731
17. S. Schaal, H.G. Kaplan, and T.H. Tezel Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology 115 12 2008 2199 2205
18. S.S. Wickremasinghe, K. Michalova, and J. Gilhotra Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration Ophthalmology 115 11 2008 1911 1915
19. H.E. Grossniklaus, J.X. Ling, and T.M. Wallace Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization Mol Vis 8 2002 119 126
20. D.G. Espinosa-Heidmann, I.J. Suner, P. Hernandez, D. Monroy, K.G. Csaky, and S.W. Cousins Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization Invest Ophthalmol Vis Sci 44 8 2003 3586 3592
21. E. Sakurai, A. Anand, B.K. Ambati, N. van Rooijen, and J. Ambati Macrophage depletion inhibits experimental choroidal neovascularization Invest Ophthalmol Vis Sci 44 8 2003 3578 3585